Hi, after doing significant research, I've realized that TCHP is the international standard chemotherapy for neoadjuvant Her2 positive breast cancer. However, my wife's oncologist says he prefers AC. She just had her 1st infusion of AC. I also discovered that the AC is down dosed by 25%. Normally in the AC leg the standard dose is 60mg/m2 of doxorubicin (adriamycin) and 600 mg/m2 of cylophosphamide, however my wife's first infusion was 45mg/m2 of doxorubicin and 600mg/m2 of cyclophosphamide. I haven't read anywhere about this down dose. Her symptoms were extremely mild after 1 week, just some fatigue, taste change, and some brain fog. We are happy for the lessened symptoms but now I am worried about the efficacy of a lower dose. Our followup is in 2 weeks. We will definately bring these issues up by I was wondering if anyone else is receiving AC/T + HP regimen for her2 positve neoadjuvant and if anyone else is familiar at all with downdosing the doxorubicin (adriamycin)?